* EU Medicines Agency recommendations for June 2017

* EU Medicines Agency recommends approval of Merck KGAA multiple sclerosis drug

* EU Medicines Agency recommends approval of Abbvie Hepatitis C combination

* EU Medicines Agency recommends approval of Novartis Kisqali drug for breast cancer

* EU Medicines Agency recommends approval of Aveo drug for kidney cancer

* EU Medicines Agency recommends approval of Abbvie biosimilar drug for rheumatoid arthritis Source text for Eikon: [bit.ly/1j4Ivvu] (Bengaluru Newsroom)